1. Emil Asprusten
Information acquired: 2025
Emil Asprusten is an academic who published a paper in 2023-10-21 entitled Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial. The paper was published in a journal entitled European Heart Journal.